• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

硝苯地平胃肠道治疗系统形成的胃石。

Nifedipine GITS (gastrointestinal therapeutic system) bezoar.

作者信息

Prisant L M, Carr A A, Bottini P B, Kaesemeyer W H

机构信息

Section of Hypertension, Medical College of Georgia, Augusta 30912-3150.

出版信息

Arch Intern Med. 1991 Sep;151(9):1868-9.

PMID:1888255
Abstract

In a patient with a gastroplasty, gastric outlet obstruction developed after the dosage of nifedipine GITS (gastrointestinal therapeutic system) was increased from 30 to 60 mg/d. The hard, insoluble shell for this extended-release tablet appears causative.

摘要

在一名接受胃成形术的患者中,硝苯地平胃肠道治疗系统(GITS)的剂量从30毫克/天增加到60毫克/天后,出现了胃出口梗阻。这种缓释片剂的坚硬、不溶性外壳似乎是病因。

相似文献

1
Nifedipine GITS (gastrointestinal therapeutic system) bezoar.硝苯地平胃肠道治疗系统形成的胃石。
Arch Intern Med. 1991 Sep;151(9):1868-9.
2
Bezoar formed by fragments of extended-release nifedipine tablets.由硝苯地平缓释片碎片形成的胃石。
Clin Pharm. 1993 Nov;12(11):849-52.
3
Nifedipine gastrointestinal therapeutic system (GITS) as an alternative to slow-release for tocolysis--tolerance and pharmacokinetic profile.
Eur J Obstet Gynecol Reprod Biol. 2008 Sep;140(1):27-32. doi: 10.1016/j.ejogrb.2008.02.003. Epub 2008 Apr 3.
4
[Pharmacobezoar in a patient operated on for pyloric stenosis].[一名因幽门狭窄接受手术治疗患者的胃石症]
Farm Hosp. 2004 Jan-Feb;28(1):59-63.
5
Extended-release nifedipine bezoar identified one year after discontinuation.停用硝苯地平缓释片一年后发现药物缓释片形成的胃石。
Ann Pharmacother. 2000 Jul-Aug;34(7-8):862-4. doi: 10.1345/aph.19112.
6
Comparative efficacy of two long-acting formulations of nifedipine in the treatment of hypertension. The Switch Study Investigators.
Can J Cardiol. 1995 Nov;11(10):913-7.
7
Colonic medication bezoar from extended-release nifedipine and procainamide.由缓释硝苯地平和普鲁卡因胺形成的结肠药物性粪石。
Arch Fam Med. 1995 Aug;4(8):715-7. doi: 10.1001/archfami.4.8.715.
8
Increased risk in esophageal obstruction with slow-release medications.缓释药物导致食管梗阻的风险增加。
J Assoc Acad Minor Phys. 1997;8(2):38-42.
9
Gastric bezoars after adjustable gastric banding.可调节胃束带术后胃石症
Obes Surg. 2004 Jun-Jul;14(6):796-7. doi: 10.1381/0960892041590845.
10
Innovative drug delivery systems in cardiovascular medicine: nifedipine-GITS and clonidine-TTS.
Cardiol Clin. 1987 Nov;5(4):703-16.

引用本文的文献

1
Rectal Bezoar: A Rare Cause of Intestinal Obstruction.直肠粪石:肠梗阻的罕见病因
Cureus. 2023 Mar 3;15(3):e35726. doi: 10.7759/cureus.35726. eCollection 2023 Mar.
2
Gastric Bezoar: Cause of Weight Loss in a Patient With Previous Bariatric Surgery.胃石:既往接受过减肥手术患者体重减轻的原因
Cureus. 2021 Dec 3;13(12):e20139. doi: 10.7759/cureus.20139. eCollection 2021 Dec.
3
Trichobezoar-Induced Heartburn in a Teenage Girl: A Case Report.一名少女因毛粪石引发的胃灼热:病例报告
J Investig Med High Impact Case Rep. 2018 May 18;6:2324709618776345. doi: 10.1177/2324709618776345. eCollection 2018 Jan-Dec.
4
Antihypertensive pharmacobezoar.抗高血压药粪石
J Clin Hypertens (Greenwich). 2006 Apr;8(4):296-8. doi: 10.1111/j.1524-6175.2006.05179.x.
5
Drug delivery systems for treatment of systemic hypertension.用于治疗全身性高血压的药物递送系统。
Clin Pharmacokinet. 2003;42(11):931-40. doi: 10.2165/00003088-200342110-00001.
6
Gastrointestinal safety of an extended-release, nondeformable, oral dosage form (OROS: a retrospective study.一种缓释、不可变形口服剂型(OROS)的胃肠道安全性:一项回顾性研究
Drug Saf. 2002;25(14):1021-33. doi: 10.2165/00002018-200225140-00004.
7
Bezoars: implicated drugs and avoidance strategies.胃石:相关药物及预防策略
Drug Saf. 1996 Feb;14(2):85-93. doi: 10.2165/00002018-199614020-00003.
8
The nifedipine gastrointestinal therapeutic system (GITS). Evaluation of pharmaceutical, pharmacokinetic and pharmacological properties.硝苯地平胃肠道治疗系统(GITS)。药物、药代动力学和药理学特性评估。
Clin Pharmacokinet. 1996 Jan;30(1):28-51. doi: 10.2165/00003088-199630010-00003.
9
Novel oral drug formulations. Their potential in modulating adverse effects.新型口服药物制剂。它们在调节不良反应方面的潜力。
Drug Saf. 1994 Mar;10(3):233-66. doi: 10.2165/00002018-199410030-00005.
10
Controlled release drugs in overdose. Clinical considerations.过量服用的控释药物。临床考量。
Drug Saf. 1995 Jan;12(1):73-84. doi: 10.2165/00002018-199512010-00006.